Skip to content

Evaluation of the Brazilian cardioprotective diet in hypertensive patients

Evaluation of the effectiveness of Brazilian Cardioprotective Alimentation in reducing Blood Pressure and its associated risk factors in hypertensive users of BHU in Salvador/Bahia: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3jzp8gv
Enrollment
Unknown
Registered
2022-05-10
Start date
2022-04-13
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Experimental Group: 300 adult users with arterial hypertension will receive nutritional guidance based on the parameters of the Brazilian Cardioprotective Diet. Comparison Group: 300 adult users with
monthly group sessions by nutritionists.
G07.203.650.240
D002316

Sponsors

Universidade do Estado da Bahia
Lead Sponsor
Universidade do Estado da Bahia
Collaborator

Eligibility

Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: Hypertensive men and women; with proven diagnosis; adults; older than 20 years; who have not been on a diet for 6 months.

Exclusion criteria

Exclusion criteria: Users with any neurocognitive condition or mental disorder (defined by their clinical history or clinical investigation); pregnant women; nursing mothers; users with liver failure; previous history of encephalopathy or anasarca; renal failure; with indication for dialysis; severe congestive heart failure; previous organ transplantation; gastroplasty; life expectancy of less than 6 months; wheelchair user and with difficulty receiving oral diet.

Design outcomes

Primary

MeasureTime frame
1. Detect a difference of 7 mmHg in systolic blood pressure, determined using an electronic sphygmomanometer, at each visit from the beginning to the end of the study (monthly visits).

Secondary

MeasureTime frame
1. A 5% reduction in blood glucose is expected, as measured by laboratory tests performed at the beginning and at the end of the study.;2. Reduction of approximately 3.5% in the Body Mass Index, measured before and after intervention.;3. Reduction in calorie intake, measured by collecting a recall and calculating it in a specific program, by approximately 10% of daily calories.

Countries

Brazil

Contacts

Public ContactEdilene Maria Almeida

Universidade do Estado da Bahia

emaraujo@uneb.br+55(71)999772922

Outcome results

None listed

Source: REBEC (via WHO ICTRP)